July 2012

José Ramon Naranjo: “Inhibiting DREAM could improve the Huntington disease”

“The inhibition of DREAM could improve Huntington disease”, said Dr. José Ramón Naranjo from the Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB-CSIC), in his seminar “DREAM: interactions, targets and functions” at the Hospital Duran i Reynals last July 6th. DREAM is a transcriptional repressor in the nucleus and regulates the traffic […]

José Ramon Naranjo: “Inhibiting DREAM could improve the Huntington disease” Read More »

Laboratory technician students from Portugal visited IDIBELL

Five students for laboratory technician from Portugal visited today IDIBELL facilities. On arrival, the laboratory technician from the Neurometabolic diseases research group Juan Jose Martínez has talk about the work of laboratory technicians in a research centre as the IDIBELL. Then, the students have visited the animal facilities, where technician Rosa Bonavia explained the functioning

Laboratory technician students from Portugal visited IDIBELL Read More »

More shadows than lights in the smoke-free laws

On July 5, one hundred participants and twenty speakers from different countries met at this International Symposium, jointly organized by the ICO and the WHO. This first Symposium was devoted to analyzing the experience of Spain and other countries that have implemented partial smoke-free laws or that have suffered regressive processes by the establishment of

More shadows than lights in the smoke-free laws Read More »

Jason Mundin: “It was a simple idea, but the most complicated was to make it work”

Jason Mundin, MBA, Director of Collaborations at Population Genetics, gave a Knowledge and Technology Transfer seminar, presenting his company, last 25th July in IDIBELL. Population Genetics, created in 2005 by Dr Sydney Brenner, Nobel Laureate in Medicine, has developed novel sequencing approaches to identify variants in candidate genomic regions in populations ranging in size from

Jason Mundin: “It was a simple idea, but the most complicated was to make it work” Read More »

A bone scan tracks the process of osseointegration in dental implants

The study developed by researchers of the research group of the Odontological and Maxillofacial Pathology and Therapeutics at the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) concludes that bone scintigraphy may be a suitable technique for monitoring the procedure in bone integration implants. The paper has been published in the June

A bone scan tracks the process of osseointegration in dental implants Read More »

Josep Manuel Menchón, appointed new Scientific Director of IDIBELL

The Board of Trustees of IDIBELL has appointed Josep Manuel Menchón as new Scientific Director of the centre. Dr. Menchón is a renowned physician and researcher in the field of psychiatry and mental health. The new Scientific Director will replace, from October 1st, Gabriel Capellá, who has held this position since 2009. The Board has

Josep Manuel Menchón, appointed new Scientific Director of IDIBELL Read More »

Alfons Nonell: ”the application of computer tools saves time and money to researcher”

The application of computing in science has increased dramatically in recent years to the point that it is becoming common to use computational tools to understand, plan and complete the experimental results obtained in the laboratory. Alfons Nonell is CEO of Mind the Byte, a company located on the campus of Bellvitge, in the bioincubator

Alfons Nonell: ”the application of computer tools saves time and money to researcher” Read More »

Poisoning from industrial compounds can cause similar effects to ALS

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease. The study, led by Jordi Llorens, has been recently published in Neuropathology and Applied Neurobiology

Poisoning from industrial compounds can cause similar effects to ALS Read More »

Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience

Grifols the world’s third largest plasma product manufacturer and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the research and development of new therapeutic approaches for tumors for which there

Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience Read More »

Barbara Marte, Nature editor: ”Now we are publishing more documents than ever”

Nature, first published on 1869, is the leading weekly, international scientific journal. Most scientific journals are now highly specialized, and Nature is among the few journals that still publish original research articles across a wide range of scientific fields. Nature is a private owned publication. The Nature Published Group (NPG) includes Nature, Nature Research Journals,

Barbara Marte, Nature editor: ”Now we are publishing more documents than ever” Read More »

Scroll to Top